Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.62 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.41 |
| ▸ | USP2 | O75604 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.34 |
| ▸ | EPAS1 | Q99814 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL515417 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRTRPA1USP2MAPT | |
| SCHEMBL3119157 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRTRPA1USP2MAPT | |
| SCHEMBL347298 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRTRPA1USP2MAPT | |
| SCHEMBL28285571 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRTRPA1USP2MAPT | |
| SCHEMBL14675841 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRTRPA1USP2MAPT | |
| SCHEMBL515877 | 1.00 | — | — | |
| SCHEMBL1727419 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRTRPA1USP2MAPT | |
| SCHEMBL30319228 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRTRPA1USP2MAPT | |
| SCHEMBL151637 | 0.97 | — | — | |
| SCHEMBL150327 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2941415-B1 | CROSS METATHESIS PROCESS | ARKEMA FRANCE (FR) | 2017-04-26 | — | — | EP | claimed |
| EP-2941413-B1 | PROCESS FOR THE SYNTHESIS OF OMEGA-UNSATURATED NITRILE-ACID/ESTER IN WHICH TWO TYPES OF CROSS METATHESIS ARE ALTERNATED CONSECUTIVELY, SWING PROCESS | ARKEMA FRANCE (FR) | 2016-10-19 | — | — | EP | claimed |
| EP-2566842-B1 | PROCESS FOR PREPARING SATURATED AMINO ACIDS OR SATURATED AMINO ESTERS COMPRISING A METATHESIS STEP | ARKEMA FRANCE (FR) | 2016-05-04 | — | — | EP | claimed |
| US-20150336879-A1 | PROCESS FOR THE SYNTHESIS OF OMEGA-UNSATURATED NITRILE-ACID/ESTER IN WHICH TWO TYPES OF CROSS METATHESIS ARE ALTERNATED CONSECUTIVELY, SWING PROCESS | ARKEMA FRANCE (FR) | 2015-11-26 | — | — | US | claimed |
| EP-2941415-A1 | CROSS METATHESIS PROCESS | Arkema France (FR) | 2015-11-11 | — | — | EP | claimed |
| EP-2941413-A1 | PROCESS FOR THE SYNTHESIS OF OMEGA-UNSATURATED NITRILE-ACID/ESTER IN WHICH TWO TYPES OF CROSS METATHESIS ARE ALTERNATED CONSECUTIVELY, SWING PROCESS | Arkema France (FR) | 2015-11-11 | — | — | EP | claimed |
| EP-2941414-A1 | CROSS METATHESIS PROCESS | Arkema France (FR) | 2015-11-11 | — | — | EP | claimed |
| US-9096490-B2 | Process for preparing saturated amino acids or saturated amino esters comprising a metathesis step | ARKEMA FRANCE (FR) | 2015-08-04 | — | — | US | claimed |
| US-20140194584-A1 | Process for the synthesis of w-Unsaturated nitrile-acid/ester in which two types of cross metathesis are alternated consecutively swing process | ARKEMA FRANCE (FR) | 2014-07-10 | — | — | US | claimed |
| WO-2014106766-A1 | PROCESS FOR THE SYNTHESIS OF OMEGA-UNSATURATED NITRILE-ACID/ESTER IN WHICH TWO TYPES OF CROSS METATHESIS ARE ALTERNATED CONSECUTIVELY, SWING PROCESS | ARKEMA FRANCE (FR) | 2014-07-10 | — | — | WO | claimed |
| WO-2011138051-A1 | PROCESS FOR PREPARING SATURATED AMINO ACIDS OR SATURATED AMINO ESTERS COMPRISING A METATHESIS STEP | ARKEMA FRANCE (FR) | 2011-11-10 | — | — | WO | claimed |
| US-7479531-B2 | Copolymer of ethylene and/or propylene; and octen-1-ol,7-octen-1-ol trimethylsilyl ether, octenyl acetate, 5-norbornen-2-yl acetate, 5-norbornen-2-ol and/or 5-norbornen-2-ol trimethylsilyl ether; transition metal catalyst comprising 2-arylazo- or 2-arylphosphazo- phenoxide ligand | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2009-01-20 | — | — | US | claimed |
| US-7285609-B2 | Olefin polymerization catalyst system useful for polar monomers | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-10-23 | — | — | US | claimed |
| EP-1626999-B1 | OLEFIN POLYMERIZATION CATALYST SYSTEM USEFUL FOR POLAR MONOMERS | EXXONMOBIL CHEM PATENTS INC (US) | 2007-09-26 | — | — | EP | claimed |
| US-20070197751-A1 | Olefin polymerization catalyst system useful for polar monomers | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-08-23 | — | — | US | claimed |
| EP-1626999-A1 | OLEFIN POLYMERIZATION CATALYST SYSTEM USEFUL FOR POLAR MONOMERS | Exxonmobil Chemical Patents Inc. (US) | 2006-02-22 | — | — | EP | claimed |
| US-20040260043-A1 | Olefin polymerization catalyst system useful for polar monomers | EXXONMOBIL CHEMICAL PATENTS, INC. | 2004-12-23 | — | — | US | claimed |
| WO-2004101634-A1 | OLEFIN POLYMERIZATION CATALYST SYSTEM USEFUL FOR POLAR MONOMERS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-11-25 | — | — | WO | claimed |
| US-4217299-A | Method for converting unsaturated compound having functional group | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1980-08-12 | — | — | US | claimed |
| US-3974196-A | Method for disproportionating ethylenically unsaturated compounds having functional ester groups | JAPAN SYNTHETIC RUBBER CO., LTD. (JA) | 1976-08-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150336879-A1 | PROCESS FOR THE SYNTHESIS OF OMEGA-UNSATURATED NITRILE-ACID/ESTER IN WHICH TWO TYPES OF CROSS METATHESIS ARE ALTERNATED CONSECUTIVELY, SWING PROCESS | FASN, METTL14, ALOX12 | ALDH1A1 249/4885TSHR 4629/4885TRPA1 2508/4885 |
| US-20140194584-A1 | Process for the synthesis of w-Unsaturated nitrile-acid/ester in which two types of cross metathesis are alternated consecutively swing process | FASN, METTL14, ELOVL1 | ALDH1A1 352/4885TSHR 4772/4885TRPA1 2609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.